Hyperthermia enhances radiosensitivity of colorectal cancer cells through ROS inducing autophagic cell death

Journal of Cellular Biochemistry

Volumn 119, Issue 4, 2018, Pages 3763-3774

  Ba, Ming Chen ^a   Long, Hui ^b   Wang, Shuai ^a   Wu, Yin Bing ^a   Zhang, Bo Huo ^a   Yan, Zhao Fei ^a   Yu, Fei Hong ^a   Cui, Shu Zhong ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b Guangzhou Dermatology Institute   (China)

Author keywords

autophagy; cvolorectal cancer; hyperthermia; radiotherapy; ROS

Indexed keywords

ACETYLCYSTEINE; BECLIN 1; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN; PROTEIN LC3B; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; MAP1LC3B PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; TARGET OF RAPAMYCIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL STRUCTURE; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; HCT 116 CELL LINE; HUMAN; HUMAN CELL; HYPERTHERMIA; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; MTT ASSAY; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION; UNIVERSITY; ANIMAL; COLORECTAL TUMOR; GENETICS; METABOLISM; NONOBESE DIABETIC MOUSE; PHYSIOLOGY; SCID MOUSE;

ANIMALS; APOPTOSIS; AUTOPHAGY; BECLIN-1; COLORECTAL NEOPLASMS; HCT116 CELLS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; MICROTUBULE-ASSOCIATED PROTEINS; REACTIVE OXYGEN SPECIES; TOR SERINE-THREONINE KINASES;

EID: 85040545854     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.26615     Document Type: Article

References (49)

1. Chen W, Zheng R, Zeng H, Zhang S, He J. Annual report on status of cancer in China, 2011. Chin J Cancer Res. 2015; 27:2–12.
2. Siegel EM, Eschrich S, Winter K. Epigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98–11 specimen study. Dis Colon Rectum. 2014; 57:941–957.
3. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65:87–108.
4. Lehmann K, Rickenbacher A, Jang JH, et al. New insight into hyperthermic intraperitoneal chemotherapy: induction of oxidative stress dramatically enhanced tumor killing in in vitro and in vivo models. Ann Surg. 2012; 256:730–737.
5. Devun F, Biau J, Huerre M, Croset A, Sun JS, Denys A. Colorectal cancer metastasis: the DNA repair inhibitor Dbait increases sensitivity to hyperthermia and improves efficacy of radiofrequency ablation. Radiology. 2014; 270:736–746.
6. Barsukov YA, Gordeyev SS, Tkachev SI, Fedyanin MY, Perevoshikov AG. Phase II study of concomitant chemoradiotherapy with local hyperthermia and metronidazole for locally advanced fixed rectal cancer. Colorectal Dis. 2013; 15:1107–1114.
7. Baratti D, Kusamura S, Iusco D, et al. Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients. Dis Colon Rectum. 2014; 57:858–868.
8. Atkinson RL, Zhang M, Diagaradjane P, et al. Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy. Sci Transl Med. 2010a; 2:55ra79.
9. Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia. 2001; 17:1–18.
10. Schroeder C, Gani C, Lamprecht U, von Weyhern CH, Weinmann M, Bamberg M. Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone. Int J Hyperthermia. 2012; 28:707–714.
11. Imaoka T, Ishii N, Kawaguchi I, et al. Biological measures to minimize the risk of radiotherapy-associated second cancer: a research perspective. Int J Radiat Biol. 2016; 92:289–301.
12. Kattan Z, Minig V, Leroy P, Dauca M, Becuwe P. Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells. Breast Cancer Res Treat. 2008; 108:203–215.
13. Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 2004; 7:97–110.
14. Renschler MF. The emerging role of reactive oxygen species in cancer therapy. Eur J Cancer. 2004; 40:1934–1940.
15. Zhang J, Zhao D, Xie Z, Qi Y. Down-regulation of AKT combined with radiation-induced autophagy and apoptosis roles in MCF-7 cells. Biomed Mater Eng. 2015; 26:S2259–S2265.
16. Cui K, Luo X, Xu K, Ven MM. Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants. Prog Neuropsychopharmacol Biol Psychiatry. 2004; 28:771–799.
17. Lemasters JJ, Nieminen AL, Qian T, et al. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta. 1998; 1366:177–196.
18. Senturker S, Karahalil B, Inal M, Yilmaz H, Muslumanoglu H, Gedikoglu G. Oxidative DNA base damage and antioxidant enzyme levels in childhood acute lymphoblastic leukemia. FEBS Lett. 1997; 416:286–290.
19. Nicco C, Laurent A, Chereau C, Weill B, Batteux F. Differential modulation of normal and tumor cell proliferation by reactive oxygen species. Biomed Pharmacother. 2005; 59:169–174.
20. Jabs T. Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. Biochem Pharmacol. 1999; 57:231–245.
21. Wang CC, Chen F, Kim E, Harrison LE. Thermal sensitization through ROS modulation: a strategy to improve the efficacy of hyperthermic intraperitoneal chemotherapy. Surgery. 2007; 142:384–392.
22. Chen F, Wang CC, Kim E, Harrison LE. Hyperthermia in combination with oxidative stress induces autophagic cell death in HT-29 colon cancer cells. Cell Biol Int. 2008; 32:715–723.
23. Dickinson BC, Chang CJ. Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat Chem Biol. 2011; 7:504–511.
24. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol. 2000; 279:L1005–L1028.
25. Fleury C, Mignotte B, Vayssiere JL. Mitochondrial reactive oxygen species in cell death signaling. Biochimie. 2002; 84:131–141.
26. Yorimitsu T, Klionsky DJ. Eating the endoplasmic reticulum: quality control by autophagy. Trends Cell Biol. 2007; 17:279–285.
27. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 1993; 75:241–251.
28. Vurusaner B, Poli G, Basaga H. Tumor suppressor genes and ROS: complex networks of interactions. Free Radic Biol Med. 2012; 52:7–18.
29. Zhou WH, Tang F, Xu J. Low expression of Beclin 1, associated with high Bcl-xL, predicts a malignant phenotype and poor prognosis of gastric cancer. Autophagy. 2012; 8:389–400.
30. Aladag I, Guven M, Songu M. Prevention of gentamicin ototoxicity with N-acetylcysteine and vitamin A. J Laryngol Otol. 2016; 130:440–446.
31. Reggiori F, Klionsky DJ. Autophagy in the eukaryotic cell. Eukaryot Cell. 2002; 1:11–21.
32. Wu WK, Coffelt SB, Cho CH, et al. The autophagic paradox in cancer therapy. Oncogene. 2012; 31:939–953.
33. Toth S, Nagy K, Palfia Z, Rez G. Cellular autophagic capacity changes during azaserine-induced tumour progression in the rat pancreas. Up-regulation in all premalignant stages and down-regulation with loss of cycloheximide sensitivity of segregation along with malignant transformation. Cell Tissue Res. 2002; 309:409–416.
34. Kang MR, Kim MS, Oh JE, et al. Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J Pathol. 2009; 217:702–706.
35. Choi J, Jung W, Koo JS. Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer. Histopathology. 2013; 62:275–286.
36. Lock R, Roy S, Kenific CM, Su JS, Salas E, Ronen SM. Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol Biol Cell. 2011; 22:165–178.
37. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 2007; 26:1749–1760.
38. Scherz-Shouval R, Elazar Z. Regulation of autophagy by ROS: physiology and pathology. Trends Biochem Sci. 2011; 36:30–38.
39. Ma G, Luo W, Lu J, Ma DL, Leung CH, Wang Y. Cucurbitacin E induces caspase-dependent apoptosis and protective autophagy mediated by ROS in lung cancer cells. Chem Biol Interact. 2016; 253:1–9.
40. Armour EP, McEachern D, Wang Z, Corry PM, Martinez A. Sensitivity of human cells to mild hyperthermia. Cancer Res. 1993; 53:2740–2744.
41. Zhu J, Chen X, Song Y, Zhang Y, Zhou L, Wan L. Deficit of RACK1 contributes to the spatial memory impairment via upregulating BECLIN1 to induce autophagy. Life Sci. 2016; 151:115–121.
42. Yang L, Wang F, He F, Huang L. The effect of combining interferon-alpha and gefitinib in human colon cancer cell lines. West Indian Med J. 2011; 60:107–113.
43. Cao Y, Fang Y, Cai J, et al. ROS functions as an upstream trigger for autophagy to drive hematopoietic stem cell differentiation. Hematology. 2016; 21:613–618.
44. Masunaga S, Ono K, Akaboshi M, Kawai K, Suzuki M, Kinashi Y. Augmentation in chemosensitivity of intratumor quiescent cells by combined treatment with nicotinamide and mild hyperthermia. Jpn J Cancer Res. 1997; 88:770–777.
45. Failli A, Consolini R, Legitimo A, Spisni R, Castagna M, Romanini A. The challenge of culturing human colorectal tumor cells: establishment of a cell culture model by the comparison of different methodological approaches. Tumori. 2009; 95:343–347.
46. Cho YY, Kim DJ, Lee HS, et al. Autophagy and cellular senescence mediated by Sox2 suppress malignancy of cancer cells. PLoS ONE. 8: 2013;e57172.
47. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature. 2008; 451:1069–1075.
48. Atkinson RL, Zhang M, Diagaradjane P. Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy. Sci Transl Med. 2010; 2:55ra79.
49. Klaver YL, Lemmens VE, Nienhuijs SW, Nieuwenhuijzen GA, Rutten HJ, de Hingh IH. Intraoperative radiotherapy and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Five consecutive case reports of locally advanced rectal cancer with synchronous peritoneal carcinomatosis. Strahlenther Onkol. 2013; 189:256–260.